What is US Neurosurgical Holding Net Debt Paydown Yield %?
Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt.
As of today, US Neurosurgical Holding's Net Debt Paydown Yield % was -0.99%.
US Neurosurgical Holding Net Debt Paydown Yield % Historical Data
The historical data trend for US Neurosurgical Holding's Net Debt Paydown Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
US Neurosurgical Holding Net Debt Paydown Yield % Chart
Competitive Comparison of US Neurosurgical Holding's Net Debt Paydown Yield %
For the Medical Care Facilities subindustry, US Neurosurgical Holding's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
US Neurosurgical Holding's Net Debt Paydown Yield % Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, US Neurosurgical Holding's Net Debt Paydown Yield % distribution charts can be found below:
* The bar in red indicates where US Neurosurgical Holding's Net Debt Paydown Yield % falls into.
US Neurosurgical Holding Net Debt Paydown Yield % Calculation
US Neurosurgical Holding's Net Debt Paydown Yield % for the quarter that ended in Mar. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
US Neurosurgical Holding (OTCPK:USNU) Net Debt Paydown Yield % Explanation
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.
In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.
US Neurosurgical Holding Net Debt Paydown Yield % Related Terms
Thank you for viewing the detailed overview of US Neurosurgical Holding's Net Debt Paydown Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
US Neurosurgical Holding (US Neurosurgical Holding) Business Description
US Neurosurgical Holding Inc operates as a holding company in United State. It is a medical services company that partners with hospitals and physicians to operate facilities utilizing artistic and inventive technologies in medical treatment and diagnosis. It is engaged in providing medical treatment and diagnosis services that include stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is focusing on establishing cancer centers using intensity-modulated radiation therapy. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
USNU has been successfully added to your 